LinkGevity Limited

LinkGevity, an AI-driven drug discovery company focused on longevity and age-related disease, announces its selection for the highly competitive SPACE-H Accelerator program, powered by Starburst in collaboration with NASA’s Human Research Program (NASA HRP), the Translational Research Institute for Space Health (TRISH), and Microsoft Federal (Microsoft).

A great opportunity to learn about the challenges of space travel and how our drugs can help!

LinkGevity has been selected to receive a highly competitive Women TechEU grant. This prestigious award, funded by Horizon Europe, highlights the groundbreaking nature of LinkGevity's work and positions the company among Europe's most promising deep tech startups.